The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice

BACKGROUND: The therapeutic efficacy of mesenchymal stem cells (MSCs) of different tissue origins on metabolic disorders can be varied in many ways but remains poorly defined. Here we report a comprehensive comparison of human MSCs derived from umbilical cord Wharton’s jelly (UC-MSCs), dental pulp (...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yinzhong, Wang, Lisha, Yang, Shilun, Liu, Dongyu, Zeng, Yi, Lin, Lilong, Qiu, Linhui, Lu, Jiahao, Chang, Junlei, Li, Zhihuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261817/
https://www.ncbi.nlm.nih.gov/pubmed/34233739
http://dx.doi.org/10.1186/s13287-021-02463-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261817/
https://www.ncbi.nlm.nih.gov/pubmed/34233739
http://dx.doi.org/10.1186/s13287-021-02463-x

Ejemplares similares